1-4 of 4
Alexander L Greninger
Close
Sort by
Journal Articles

CMV Reactivation during Pre-Transplantation Evaluation: A Novel Risk Factor for Post-Transplantation CMV Reactivation

Danniel Zamora, Hu Xie, Alicja Sadowska-Klasa, Eleftheria Kampouri, Melinda A Biernacki, Masumi Ueda Oshima, Elizabeth R Duke, Margaret L. Green, Louise Kimball, Dr., Leona A Holmberg, Alpana Waghmare, Alexander L Greninger, Keith R Jerome, Geoffrey R Hill, Joshua A Hill, Wendy M Leisenring, Michael J Boeckh
Journal: Blood Advances
Blood Adv bloodadvances.2023012234.
https://doi.org/10.1182/bloodadvances.2023012234
Published: 2024
Includes: Supplemental data
Journal Articles

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Chaitra Ujjani, Ted A. Gooley, Stephen E. Spurgeon, Deborah M. Stephens, Catherine Lai, Catherine M. Broome, Susan O’Brien, Haiying Zhu, Kerry J. Laing, Allison M. Winter, Georgios Pongas, Alexander L Greninger, David M. Koelle, Tanya Siddiqi, Matthew S. Davids, Kerry A. Rogers, Alexey V. Danilov, Amy Sperling, Brian Tu, Tyler Sorensen, Kelsey Launchbury, Carlissa J. Burrow, Genesis Quezada, Joshua A. Hill, Mazyar Shadman, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4728–4737.
https://doi.org/10.1182/bloodadvances.2022009164
Published: 2023
Includes: Supplemental data
Journal Articles

Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy

Clinical Trials & Observations
Michael A. Gonzalez, Atif M. Bhatti, Kristin Fitzpatrick, Jim Boonyaratanakornkit, Meei-Li Huang, Victoria L. Campbell, Jessica Hecht, Sarah Ibrahimi, Shera N. Wanner, Damian J. Green, David G. Maloney, Jordan Gauthier, Andrew J. Cowan, Alexander L. Greninger, Elizabeth M. Krantz, David M. Koelle, Joshua A. Hill
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1849–1853.
https://doi.org/10.1182/bloodadvances.2022008338
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Clinical Trials & Observations
Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A. Gooley, Heather Rasmussen, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward N. Libby, III, Alexander L. Greninger, Jonathan R. Fromm, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (5): 687–696.
https://doi.org/10.1182/bloodadvances.2022008628
Published: 2023
Includes: Supplemental data